KZR vs BIIB: Which Stock is Better?
Side-by-side comparison of Kezar Life Sciences Inc and Biogen Inc in 2026
KZR
Kezar Life Sciences Inc
$7.33
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | KZR | BIIB | Winner |
|---|---|---|---|
| Market Cap | $54.33M | $26.03B | BIIB |
| P/E Ratio | N/A | 20.04 | BIIB |
| EPS (TTM) | $N/A | $8.85 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 0.0% | 78.9% | BIIB |
Analyze KZR
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KZR or BIIB a better investment?
Comparing KZR and BIIB: Kezar Life Sciences Inc has a market cap of $54.33M while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KZR and BIIB?
KZR (Kezar Life Sciences Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KZR or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KZR or BIIB?
KZR has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: KZR or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 0.0% for KZR.
Which is the larger company: KZR or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $54.33M for KZR.
Should I buy KZR or BIIB in 2026?
Both KZR and BIIB have investment merit. KZR trades at $7.33 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KZR and BIIB stock?
Key differences: Market Cap ($54.33M vs $26.03B), P/E Ratio (N/A vs 20.0x), Revenue Growth (0.0% vs -0.1%), Gross Margin (0.0% vs 78.9%).